Clinical Trials in San Francisco

Showing 1361-1380 of 12,991 trials

GCC19CART for Patients With Metastatic Colorectal Cancer

NCT05319314

Study ICT-GCC19CART-US-001 (CARAPIA-1) is a Phase 1 study evaluating the safety, tolerability, clinical activity, pharmacokinetics and pharmacodynamics of GCC19CART in subjects with relapsed or refractory metastatic colorectal cancer.

Colorectal Cancer

Lyell Immunopharma, Inc.30 participantsStarted Aug 2022

Duarte, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +1 more locations

RECRUITINGPhase 1/2< 1 mile

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

NCT06961071

This study is being done to see if transplanting parathyroid tissue into the forearm will help hypo-parathyroid patients achieve parathyroid hormone (PTH) levels that would help normalize their serum calcium and phosphorus levels. The parathyroid tissue used in this study will come from cadaveric tissues that were donated at the time of the death of the donor(s).

HypoparathyroidismHypoparathyroidism PostproceduralHypoparathyroidism Post-surgical

Peter Stock3 participantsStarted Jan 2026

San Francisco, California, United States

COMPLETEDNA< 1 mile

Establishing Clinical Utility Evidence for Chronic Disease Management Testing

NCT05192590

This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.

Cardiometabolic Syndrome

Qure Healthcare, LLC247 participantsStarted Oct 2021

San Francisco, California, United States

GCC19CART for Patients With Metastatic Colorectal Cancer

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

Establishing Clinical Utility Evidence for Chronic Disease Management Testing

Find Trials by Condition in San Francisco

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

ADVENT Post Approval Study

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG